Lila Biologics, Inc.
Seattle, US · Founded 2022 · Delaware corporation · 1 known investors
Founders & leadership
SG
Sheila GujrathiNamed on SEC filing
JK
John Kraft, IINamed on SEC filing
AR
Anindya RoyNamed on SEC filing
Board
WC
William CanestaroBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$9.5M disclosed across 1 round · 2023
▶$9.5MraisedSep 2023 · 18 investors · BiotechnologyRule 506(b)
▶$9.5MraisedSep 2023 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William CanestaroDirector
- Sheila GujrathiDirector
- John Kraft, IIExecutive Officer, Director
- Anindya RoyExecutive Officer, Director
- Offering amount
- $10.6M
- Amount sold
- $9.5M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Lila Biologics, Inc.'s investors?
- Lila Biologics, Inc.'s investors include SilverArc Private.
- How much funding has Lila Biologics, Inc. raised?
- Lila Biologics, Inc. has disclosed $9.5M raised across 1 round.
- Where is Lila Biologics, Inc. headquartered?
- Lila Biologics, Inc. is headquartered in Seattle, US.